About Oxsed
Oxsed is a company based in United Kingdom founded in 2020 by Zhanfeng Cui was acquired by Prenetics in October 2020. The company has 9 employees as of December 31, 2021. Oxsed operates in a competitive market with competitors including Prenetics, OpGen, Day Zero Diagnostics, Clear Labs and Karius, among others.
- Headquarter United Kingdom
- Employees 9 as on 31 Dec, 2021
- Founders Zhanfeng Cui
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Oxsed Limited
- Date of Incorporation 13 May, 2020
- Jurisdiction BOLTON, ENGLAND
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Oxsed
Detailed funding history for Oxsed
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Oxsed
Oxsed has secured backing from 1 investor. Prominent investors backing the company include Prenetics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health risks are identified through online genetic and diagnostic testing.
|
Locked | Locked | Locked |
Investor details for Oxsed
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Oxsed
Investment portfolio details for Oxsed
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Oxsed
Detailed financials for Oxsed
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Oxsed Comparisons
Peer comparison for Oxsed
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Oxsed
Oxsed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prenetics, OpGen, Day Zero Diagnostics, Clear Labs and Karius, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
|
| Locked | Locked | Locked |
Developer of diagnostics and bioinformatics platforms for providers
|
|
| Locked | Locked | Locked |
Genome sequencing diagnostics for infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Food safety technologies are provided for pathogen identification.
|
|
| Locked | Locked | Locked |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| Locked | Locked | Locked |
Cloud-powered POC MDx device
|
Detailed competitors of Oxsed
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Oxsed
Complete news archive for Oxsed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oxsed
Oxsed was founded in 2020.
Oxsed is headquartered in United Kingdom.
As of Dec 31, 2021, the latest employee count at Oxsed is 9.
Oxsed was founded in 2020 in the United Kingdom within the diagnostics sector. A flagship rapid diagnostic assay, the Oxsed RaViD Direct SARS-CoV-2 Test, is offered for detecting SARS-CoV-2 infections. Nasopharyngeal swabs, saliva, and mouthwash specimens are utilized as samples. Reverse transcription loop-mediated isothermal amplification (RT-LAMP) is employed to identify viral RNA through nucleic acid amplification testing (NAAT). Operations focus on point-of-care testing for respiratory infections.
Oxsed's top competitors include Prenetics, Clear Labs and Day Zero Diagnostics.
Oxsed has 1 investor. Key investors include Prenetics.